Avrobio Inc reported -31375000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Akebia Therapeutics AKBA:US $ -26.85M 38.09M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Applied Genetic Technologies AGTC:US $ -13.79M 0.7M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Epizyme EPZM:US $ -58231000 6.11M
Gilead Sciences GILD:US $ 2246M 644M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Macrogenics MGNX:US $ -40279000 11.01M
Pfizer PFE:US $ 5914M 397M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M